An interventional study of Heights Smart Supplement in Anxiety, Stress and Memory Deficits, sponsored by Heights. Completed at 1 site in United States. Open to participants aged 21 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-11-08.
Sponsored by Heights · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 224 studies in Memory Disorders with a site in United States — 34 open to participants now, 51 under way, none of them phase 3. Memory Disorders · United States.
Among the 224 studies in Memory Disorders with a site in United States, this one is the 124th largest by enrollment of the 186 interventional ones that give a count, is one of 7 that started in 2022, is one of 124 with no phase, and was the 175th registered.
373 studies on the registry are indexed under Memory Disorders; 67 are open to participants now.
Browse Memory Disorders studies →34 of the 224 studies in Memory Disorders with a site in United States are open now. Recruiting first, the newest first:
The Cleveland Clinic · Sites in United States
Ages 18+
BrainHealth Solutions, Inc. · Sites in United States
Ages 65+
University of Texas at Austin · Sites in United States
Ages 18–90 · Healthy volunteers
Medical University of South Carolina · Sites in United States
Ages 60–85
Dartmouth-Hitchcock Medical Center · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 54 Memory Disorders studies recruiting now, 27 (50%) set no upper age limit and 13 (24%) stop at 75 or younger; 3 take children under 18; 22 take healthy volunteers.
This study: 21 Years to 70 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
224 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 17 · Phase 2 33 · Phase 3 13 · Phase 4 10
First in 1995; this study’s year is marked. 7 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 34 is below the median of 72 across 298 interventional studies indexed under Memory Disorders.
Median enrollment 68 across the 186 interventional studies, 197 across the 33 observational. Of the 159 that completed or were terminated, 49 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
35 of 224 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Heights as lead sponsor.
Heights has 1 study filed under Memory Disorders — fewer than ten, so there is no comparison to draw.
16 of the studies in Memory Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06391489Dartmouth-Hitchcock Medical CenterHOBSCOTCH for People With Post Acute COVID-19 Syndrome (PACS) | 2026-12 |
| NCT03896529Georgia Institute of TechnologyNeurobiological Mechanisms of Aging and Stress on Prospective Navigation | 2026-12-25 |
| NCT05027789University of California, DavisBrain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention | 2026-12-31 |
| NCT05611918Johns Hopkins UniversityREpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study | 2026-12-31 |
| NCT05661084Hebrew SeniorLifeNon-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia | 2026-12-31 |
Add all 16 to your calendar (.ics) → With an account.
Among the 224 studies in Memory Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The Smart Supplement has 20 vitamins and minerals that have strong track records of demonstrating positive health effects, both physiologically and cognitively. This twelve-week trial will examine the effectiveness and efficacy of Heights Smart Supplement on both biomarkers and subjective experiences from participants.
373 studies on the registry are indexed under Memory Disorders; 67 are open to participants now.
This study's enrollment of 34 is below the median of 72 across 298 interventional studies indexed under Memory Disorders.
Browse Memory Disorders studies →This is the only study on the registry with Heights as lead sponsor.
Compared within Memory Disorders, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will take the supplement over a 12 week period. There will be both biomarker outcomes and subjective outcomes reported by the participants via questionnaires.
Dietary Supplement: Heights Smart Supplement
The ingredient list of the product includes the following: Algae oil Blueberry Extract Methylcobalamin (Vitamin B12) Cholecalciferol (Vitamin D3) Ascorbic acid (Vitamin C) Retinol acetate (Vitamin A) Calcium L-methylfolate (Folic Acid) D-biotin Pyridoxine hydrochloride (Vitamin B6) Calcium pantothenate (Vitamin B5) Nicotinamide (Vitamin B3) Riboflavin (Vitamin B2) Thiamine hydrochloride (Vitamin B1) D-Alpha tocopheryl acetate (Vitamin E) Chromium picolinate Potassium iodide Iron Citrate Sodium selenite Zinc citrate
Changes in Measures of C-reactive protein
Biomarkers measured by a third party lab through blood samples submitted by participants.
Time frame: 12 weeks
Changes in Measures of cortisol
Biomarkers measured by a third party lab through blood samples submitted by participants.
Time frame: 12 weeks
Changes in Sleep Quality as measured via Fitness trackers and Questionnaires
Measurements taken via existing smart watches and report that data on the questionnaires.
Time frame: 12 weeks
examine the subjective experiences of participants taking the Heights Smart Supplement.
The questionnaires for this study are specifically designed to understand changes in focus, anxiety embedded in mood \& stress, memory, and overall well-being.
Time frame: 12 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Jun 2022 to primary completion in Oct 2022, 3 months.
Of 138 interventional studies with no phase under Memory Disorders, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 3 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.